GSA Capital Partners LLP Grows Holdings in Phreesia, Inc. (NYSE:PHR)

GSA Capital Partners LLP raised its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 418.3% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 49,553 shares of the company's stock after purchasing an additional 39,993 shares during the quarter. GSA Capital Partners LLP owned 0.09% of Phreesia worth $1,129,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Capital International Investors raised its stake in Phreesia by 221.1% during the 1st quarter. Capital International Investors now owns 2,593,063 shares of the company's stock valued at $62,052,000 after buying an additional 1,785,463 shares during the last quarter. Champlain Investment Partners LLC bought a new position in Phreesia in the 1st quarter worth $29,941,000. Blair William & Co. IL increased its holdings in Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company's stock worth $18,012,000 after acquiring an additional 224,950 shares in the last quarter. Deerfield Management Company L.P. Series C bought a new position in shares of Phreesia in the second quarter worth approximately $4,078,000. Finally, Sei Investments Co. raised its stake in Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company's stock valued at $3,505,000 after purchasing an additional 95,058 shares during the period. Institutional investors own 92.10% of the company's stock.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 14,110 shares of the company's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $26.03, for a total value of $367,283.30. Following the completion of the sale, the general counsel now directly owns 121,003 shares in the company, valued at $3,149,708.09. This represents a 10.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Yvonne Hui sold 2,791 shares of Phreesia stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total value of $58,387.72. Following the transaction, the insider now owns 27,228 shares in the company, valued at approximately $569,609.76. This represents a 9.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,107 shares of company stock valued at $1,035,226 over the last ninety days. Insiders own 5.80% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have commented on PHR. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price target on shares of Phreesia in a research note on Thursday, September 5th. DA Davidson reissued a "buy" rating and set a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial boosted their price target on Phreesia from $29.00 to $31.00 and gave the company a "buy" rating in a report on Friday, September 6th. Robert W. Baird boosted their price target on shares of Phreesia from $31.00 to $34.00 and gave the company an "outperform" rating in a report on Friday, September 6th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $29.42.

Phreesia Price Performance

Shares of Phreesia stock traded down $2.96 on Friday, hitting $18.04. The company's stock had a trading volume of 1,022,045 shares, compared to its average volume of 449,920. Phreesia, Inc. has a 1 year low of $14.55 and a 1 year high of $29.16. The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of -10.39 and a beta of 0.94. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77. The firm has a fifty day moving average price of $21.39 and a 200-day moving average price of $22.03.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping analysts' consensus estimates of ($0.37) by $0.06. The business had revenue of $102.12 million during the quarter, compared to analysts' expectations of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. As a group, sell-side analysts anticipate that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.